SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is buzzing with conversation after its recent financial update, which showcased impressive membership growth and an optimistic 2026 outlook, fueling bullish enthusiasm despite concerns over a quarterly performance miss and ongoing uncertainty surrounding broader healthcare policy.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending amid a broad software sector sell-off, fueled by investor concerns that rapidly advancing AI will disrupt or replace traditional SaaS models. While some analysts and market participants argue that AI will enhance core enterprise software and point to a significant government contract, the community remains polarized between those calling it a "generational buying opportunity" and those fearing further valuation compression.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is trending due to its strong Q4 earnings beat and robust subscriber growth, alongside recent premium subscription price increases. The community is widely debating if these positive catalysts, coupled with new AI features and video content, can reverse the stock's recent downtrend and its perceived correlation with Netflix's performance, as many consider it oversold.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending following strong Q4 earnings and a new share buyback, prompting community debate over its significant stock-based compensation and dilutive practices, particularly as reports circulate about Meta's Instagram developing a rival app.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv (FISV) is actively trending as investors keenly await its earnings report, fueling intense community debate between those who believe the stock is deeply undervalued with a promising turnaround under new leadership, and others bracing for a significant drop mirroring previous disappointments and broader fintech sector headwinds. Significant options activity indicates widespread expectation of a volatile price movement following the announcement.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending after the FDA issued a Complete Response Letter for its Hunter syndrome gene therapy, RGX-121, citing concerns over trial design and efficacy evidence, compounding worries from an earlier clinical hold related to a brain tumor in a related gene therapy. The community is actively debating the severe financial implications of this setback, exacerbated by multiple downgrades, though some hold hope for other pipeline assets like the AbbVie-partnered RGX-314.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending after securing crucial Medicare coverage for its ultra-sensitive Molecular Residual Disease (MRD) test, marking a significant de-risking milestone for the company. The community is highly optimistic about this pivotal step, anticipating substantial revenue growth and further approvals to solidify Personalis's position in the rapidly evolving cancer diagnostics market.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is trending due to the abrupt departures of its CFO and General Counsel amid an ongoing accounting review, delayed SEC filings, and internal control weaknesses, which has the community intensely debating severe credibility risks and drawing comparisons to other companies that faced similar financial reporting challenges.

Upwork, Inc. is an online marketplace which engages in the provision of businesses to find, hire, and pay freelancers for short-term and longer-term projects. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The company was founded by Odysseas Tsatalos and Efstratios Karamanlakis in December 2013 and is headquartered in Palo Alto, CA.

Upwork Inc

Upwork is trending lower following mixed guidance for the upcoming quarter and fiscal year, despite reporting stronger-than-expected Q4 earnings. This has ignited a contentious debate among investors, with many fearing AI will render its services obsolete, while others view the pullback as a prime buying opportunity, banking on the company's stated focus on human-plus-AI collaboration.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending following strong Q4 2025 financial results and positive FY26 guidance, bolstered by recent FDA approvals for its oncology blockbusters Enhertu and Datroway, and groundbreaking Phase 3 data for hypertension treatment Baxdrostat. The community is actively discussing the company's strategic direct listing on the NYSE, along with significant investments in US manufacturing and an expanding obesity pipeline in China, all signaling a robust long-term growth outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The team has been working with Danish engineering firm NIRAS and advancing final engineering and design work for both near-term and long-lead components.</li><li>Critical Metals also announced the renewal of the Wolfsberg lithium mining license for two years.</li><li>The project is designed to produce spodumene concentrate for battery and electric vehicle manufacturers.</li></ul>Shares of Critical Metals Corp. (CRML) jumped 5% on Friday after the company announced updates on its European operations, including the key Tanbreez project in Greenland.The company has assembled a new project management team to accelerate development of its flagship Tanbreez rare earths project amid intensifying global competition for critical mineral supply outside China.&nbsp;&nbsp;The team has been working with Danish engineering firm NIRAS and coordinating with partners across Greenland, the U.S., Europe, and the Middle East. The project delivery team is advancing final engineering and design work for both near-term and long-lead components, Critical Metals said.<h2 class="st-heading-2">Why Tanbreez Matters</h2>Tanbreez hosts one of the world’s largest known rare-earth deposits and sits close to North Atlantic shipping routes, giving it strong logistical advantages. Recent drilling confirmed consistent rare-earth grades along with valuable by-products such as gallium, hafnium, cerium, and yttrium.Rare earth elements are essential for electric vehicles, wind turbines, defense systems, and advanced electronics, with the supply chain currently dominated by China. That strategic importance has pushed Greenland into the geopolitical spotlight and has been one of the factors behind U.S. President Donald Trump’s plans to acquire the territory.Trump has since then softened his stance on Greenland, saying he would not pursue a takeover by force or impose tariffs on countries that opposed him.<h2 class="st-heading-2">Austrian Mine Permit Secured</h2>Separately, Critical Metals said the Austrian government has renewed the Wolfsberg lithium mining license for two years. Wolfsberg is one of Europe’s most advanced hard-rock lithium projects, designed to produce spodumene concentrate for battery and electric vehicle (EV) manufacturers.Amid rising lithium prices, the extended license provides regulatory clarity as the company weighs the start of mining, with a final decision expected by the end of 2026.“We have recently met with Obeikan (our Saudi hydroxide plant partners) and agreed a framework for a ‘decision to mine’ by the end of 2026 if prices remain robust and financing options are available,” said Tony Sage, Chairman of Critical Metals.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>While retail sentiment on Stocktwits shifted to ‘neutral’ from ‘bullish’ a day earlier, chatter was largely positive.One user said, given&nbsp;the scale and strategic importance of the minerals, “Success is a foregone conclusion.”<stembedurl>https://stocktwits.com/Lewi5/message/643436040</stembedurl>Another user saw positive catalysts on multiple fronts.<stembedurl>https://stocktwits.com/Kirk24/message/643443458</stembedurl>The stock has rallied strongly in 2026, surging by more than 110%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-hdsn-shares-fall-today/cmySmpyR4SJ">HDSN Stock In Spotlight As Contract With US DLA Comes Under Legal Scrutiny</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Mountain Pass Rare Earth Mine & Processing Facility, owned by MP Materials

Why Did CRML Stock Jump 5% Today?

The company announced it has assembled a new project management team to accelerate development of its flagship Tanbreez rare earths project in Greenland.

Equity

Suite includes two first-to market funds, CRMX and PATX, that seek to provide 200% long exposureNEW YORK, Jan. 13, 2026 /PRNewswire/ -- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=2355447185&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a>, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new single stock leveraged ETFs. The funds seek to deliver twice (200%) the daily performance of a specific underlying stock. Listed on Cboe, these ETFs represent Tradr's first ETF launches of 2026.The following ETFs are expected to open for trading today:<ul><li>Tradr 2X Long CRML Daily ETF (Cboe: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=2929393436&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fcrmx&amp;a=CRMX">CRMX</a>) – tracks Critical Metals Corp. (Nasdaq: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-leveraged-etfs-on-critical-metals-ondas-holdings-uipath-and-usa-rare-earth-302659206.html#financial-modal">CRML</a>)</li><li>Tradr 2X Long ONDS Daily ETF (Cboe: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=1614405455&amp;u=https%3A%2F%2Fwww.tradretfs.com%2Fondu&amp;a=ONDU">ONDU</a>) – tracks Ondas Holdings Inc. (Nasdaq: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-leveraged-etfs-on-critical-metals-ondas-holdings-uipath-and-usa-rare-earth-302659206.html#financial-modal">ONDS</a>)</li><li>Tradr 2X Long PATH Daily ETF (Cboe: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=3426305981&amp;u=http%3A%2F%2Fwww.tradretfs.com%2Fpatx&amp;a=PATX">PATX</a>) – tracks UiPath Inc. (NYSE: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-leveraged-etfs-on-critical-metals-ondas-holdings-uipath-and-usa-rare-earth-302659206.html#financial-modal">PATH</a>)</li><li>Tradr 2X Long USAR Daily ETF (Cboe: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=3112671881&amp;u=https%3A%2F%2Fwww.tradretfs.com%2Fusax&amp;a=USAX">USAX</a>) – tracks USA Rare Earth Inc. (Nasdaq: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tradr-launches-leveraged-etfs-on-critical-metals-ondas-holdings-uipath-and-usa-rare-earth-302659206.html#financial-modal">USAR</a>)</li></ul>"After 47 fund launches in 2025, we are excited to continue the momentum into 2026," said Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs. "This newest suite of funds touches on some hot button themes that garnered an enormous amount of investor attention in the latter half of last year, namely drone technology and rare earth resources. Meanwhile, UiPath is a standout story in the area of agentic automation, a topic we expect to attract considerable interest in 2026 as efficiency gains related to the use of AI become more tangible."In 2022, Tradr ETFs became the first issuer to launch leveraged ETFs on single stocks, starting with TSLQ for Tesla and NVDS for Nvidia. With today's listings, Tradr's lineup has grown to 58 leveraged ETFs representing over $2 billion in assets under management. Tradr's strategies can be accessed through most brokerage platforms and allow investors to avoid the hassle of using margin and the complexity of options trading. The firm continues its mission of providing sophisticated investors with innovative trading tools that enhance their ability to express market views with precision and efficiency.For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=1051652352&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>.About Tradr ETFs <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=2355447185&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=Tradr+ETFs">Tradr ETFs</a> are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.IMPORTANT RISK INFORMATIONTradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund's return as much as, or more than, the return of the underlying security.Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.Leverage increases the risk of a total loss of an investor's investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund's underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4594180-1&amp;h=1051652352&amp;u=http%3A%2F%2Fwww.tradretfs.com%2F&amp;a=www.tradretfs.com">www.tradretfs.com</a>. The Prospectus should be read carefully before investing.Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000825SOURCE Tradr ETFsNote: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Tradr Launches Leveraged ETFs on Critical Metals, Ondas Holdings, UiPath and USA Rare Earth

Tradr ETFs has launched four new single-stock leveraged ETFs designed to provide 200% daily long exposure to Critical Metals Corp., Ondas Holdings, UiPath, and USA Rare Earth.

Others

Investment Managers Series Trust II - Tradr 2X Long CRML Daily ETF

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

CRMX
Tradr 2X Long CRML Daily ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest CRMX News

CRMXTradr 2X Long CRML Daily ETF